carbapenems has been researched along with rifamycins in 2 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (rifamycins) | Trials (rifamycins) | Recent Studies (post-2010) (rifamycins) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 2,351 | 203 | 626 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamiya, S; Taguchi, H | 1 |
| Nuermberger, EL; Spigelman, MK; Yew, WW | 1 |
2 review(s) available for carbapenems and rifamycins
| Article | Year |
|---|---|
[Prospect of the development of new bactericidal drugs against Helicobacter pylori for eradication therapy].
Topics: Animals; Anti-Bacterial Agents; Benzenesulfonates; Carbapenems; Cetylpyridinium; Drug Design; Drug Resistance, Bacterial; Ellagic Acid; Fish Oils; Food Analysis; Glycyrrhizic Acid; Helicobacter Infections; Helicobacter pylori; Nitrofurantoin; Rifamycins; Thiazoles | 2002 |
Current development and future prospects in chemotherapy of tuberculosis.
Topics: Adamantane; Animals; Antitubercular Agents; Carbapenems; Clinical Trials as Topic; Diarylquinolines; Drug Delivery Systems; Ethylenediamines; Fluoroquinolones; Humans; Isonicotinic Acids; Mice; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Patient Compliance; Pyrroles; Quinolines; Rifamycins; Tuberculosis, Pulmonary | 2010 |